Literature DB >> 29090990

Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition.

Carlos H Martinez1, Alejandro A Diaz2, Catherine A Meldrum1, Merry-Lynn N McDonald3, Susan Murray4, Gregory L Kinney5, John E Hokanson5,6, Jeffrey L Curtis1, Russell P Bowler7, MeiLan K Han1, George R Washko2, Elizabeth A Regan7.   

Abstract

RATIONALE: Handgrip strength (HGS) predicts mortality in the elderly, but its determinants and clinical significance in chronic obstructive pulmonary disease (COPD) has not been defined.
OBJECTIVES: We tested associations of HGS with pectoralis muscle area (PMA), subcutaneous adipose tissue (SAT), imaging characteristics, and lung function in smokers with COPD, and evaluated the cross-sectional and longitudinal associations of HGS with acute respiratory events.
METHODS: We analyzed demographic, clinical, spirometry, HGS, and imaging data of 272 subjects with COPD, obtaining measures of airway thickness, emphysema, PMA, and SAT from chest computed tomography scans. We tested associations of lung function and imaging characteristics with HGS, using linear models. HGS association to acute respiratory events at enrollment and during follow-up (mean, 2.6 years) was analyzed using adjusted logistic models.
RESULTS: HGS correlated with PMA, SAT, forced expiratory volume, and airway thickness, but not with body mass index or emphysema severity. In adjusted regression models, HGS was directly (β, 1.5; 95% confidence interval [CI], 0.1-3.0) and inversely (β, -3.3; 95% CI, -5.1 to -0.9) associated with one standard deviation of PMA and SAT, respectively, independent of body mass index and emphysema. In regression models adjusted for age, sex, body mass index, race, pack-years smoked, current smoking, chronic bronchitis, FEV1% predicted, emphysema, and airway metrics, HGS was associated with exacerbation risk; in cross-sectional analyses, there was an increment of 5% in the risk of exacerbations for each 1-kg decrement in HGS (risk ratio, 1.05; 95% CI, 1.01-1.08), and there was a similar risk during follow-up (risk ratio, 1.04; 95% CI, 1.01-1,07).
CONCLUSIONS: In ever-smokers with COPD, HGS is associated with computed tomography markers of body composition and airway thickness, independent of body mass index and emphysema. Higher HGS is associated with lower exacerbation frequency.

Entities:  

Keywords:  Body Mass Index; COPD symptom flare up; adult; cohort studies; computed tomography

Mesh:

Year:  2017        PMID: 29090990      PMCID: PMC5711268          DOI: 10.1513/AnnalsATS.201610-821OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  44 in total

1.  Comparing models of frailty: the Health and Retirement Study.

Authors:  Christine T Cigolle; Mary Beth Ofstedal; Zhiyi Tian; Caroline S Blaum
Journal:  J Am Geriatr Soc       Date:  2009-04-21       Impact factor: 5.562

2.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

3.  Comparison between handgrip strength, subjective global assessment, and prognostic nutritional index in assessing malnutrition and predicting clinical outcome in cirrhotic outpatients.

Authors:  Mário Reis Alvares-da-Silva; Themis Reverbel da Silveira
Journal:  Nutrition       Date:  2005-02       Impact factor: 4.008

Review 4.  Body composition by whole-body bioelectrical impedance and prediction of clinically relevant outcomes: overvalued or underused?

Authors:  M Elia
Journal:  Eur J Clin Nutr       Date:  2013-01       Impact factor: 4.016

5.  Frailty in older adults: evidence for a phenotype.

Authors:  L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2001-03       Impact factor: 6.053

6.  Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease.

Authors:  R Gosselink; T Troosters; M Decramer
Journal:  J Cardiopulm Rehabil       Date:  2000 Nov-Dec       Impact factor: 2.081

7.  Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study.

Authors:  Jeffrey I Stewart; Sarah Moyle; Gerard J Criner; Carla Wilson; Ron Tanner; Russell P Bowler; James D Crapo; Robert K Zeldin; Barry J Make; Elizabeth A Regan
Journal:  COPD       Date:  2012-06-07       Impact factor: 2.409

8.  Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease.

Authors:  Karine Marquis; Richard Debigaré; Yves Lacasse; Pierre LeBlanc; Jean Jobin; Guy Carrier; François Maltais
Journal:  Am J Respir Crit Care Med       Date:  2002-09-15       Impact factor: 21.405

9.  Chronic obstructive pulmonary disease, cognitive impairment, and development of disability: the health and retirement study.

Authors:  Carlos H Martinez; Caroline R Richardson; MeiLan K Han; Christine T Cigolle
Journal:  Ann Am Thorac Soc       Date:  2014-11

10.  Simple functional performance tests and mortality in COPD.

Authors:  Milo A Puhan; Lara Siebeling; Marco Zoller; Patrick Muggensturm; Gerben ter Riet
Journal:  Eur Respir J       Date:  2013-03-21       Impact factor: 16.671

View more
  17 in total

1.  Circulating Biomarkers of Handgrip Strength and Lung Function in Chronic Obstructive Pulmonary Disease.

Authors:  Rizwan Qaisar; Asima Karim; Tahir Muhammad
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-02-11

Review 2.  Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review.

Authors:  Yong Suk Jo
Journal:  Tuberc Respir Dis (Seoul)       Date:  2022-07-13

3.  Serum Creatinine to Cystatin C Ratio is an Effective Indicator for Muscle Strength Decline in Men with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Dan Huang; Canhui Xie; Chaoqun Sun; Min Chen; Lian Li; Huajuan Yi; Jinyu Liao; Xuanna Zhao; Xiaoping Shen; Donglan He; Dongming Li; Dong Wu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-04-08

Review 4.  Handgrip Strength and Pulmonary Disease in the Elderly: What is the Link?

Authors:  Tatiana Rafaela Lemos Lima; Vívian Pinto Almeida; Arthur Sá Ferreira; Fernando Silva Guimarães; Agnaldo José Lopes
Journal:  Aging Dis       Date:  2019-10-01       Impact factor: 6.745

5.  Decreased handgrip strength can predict lung function impairment in male workers: a cross sectional study.

Authors:  Makiko Kanai; Osamu Kanai; Kohei Fujita; Tadashi Mio; Masato Ito
Journal:  BMC Pulm Med       Date:  2020-04-20       Impact factor: 3.317

6.  Does hand grip strength decrease in chronic obstructive pulmonary disease exacerbation? A cross-sectional study

Authors:  Zeynep Turan; Özlem Özyemişçi Taşkıran; Zeynep Erden; Nurdan Köktürk; Gülçin Kaymak Karataş
Journal:  Turk J Med Sci       Date:  2019-06-18       Impact factor: 0.973

7.  Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk.

Authors:  Chi-Tai Lee; Ping-Huai Wang
Journal:  BMC Pulm Med       Date:  2021-07-21       Impact factor: 3.317

8.  Pectoralis muscle area and mortality in smokers without airflow obstruction.

Authors:  Alejandro A Diaz; Carlos H Martinez; Rola Harmouche; Thomas P Young; Merry-Lynn McDonald; James C Ross; Mei Lan Han; Russell Bowler; Barry Make; Elizabeth A Regan; Edwin K Silverman; James Crapo; Aladin M Boriek; Gregory L Kinney; John E Hokanson; Raul San Jose Estepar; George R Washko
Journal:  Respir Res       Date:  2018-04-10

9.  Fortified whey beverage for improving muscle mass in chronic obstructive pulmonary disease: a single-blind, randomized clinical trial.

Authors:  Afsane Ahmadi; Mohammad Hassan Eftekhari; Zohreh Mazloom; Masoom Masoompour; Mohammad Fararooei; Mohammad Hadi Eskandari; Samrad Mehrabi; Alireza Bedeltavana; Mandana Famouri; Morteza Zare; Nasrin Nasimi; Zahra Sohrabi
Journal:  Respir Res       Date:  2020-08-17

10.  Frailty in Chronic Obstructive Pulmonary Disease and Risk of Exacerbations and Hospitalizations.

Authors:  Nathan Yee; Emily R Locke; Kenneth C Pike; Zijing Chen; Jungeun Lee; Joe C Huang; Huong Q Nguyen; Vincent S Fan
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.